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Abstract
Background: Eukaryotic tRNA splicing is an essential process in the transformation of a primary tRNA transcript into
a mature functional tRNA molecule. 5′-phosphate ligation involves two steps: a healing reaction catalyzed by
polynucleotide kinase (PNK) in association with cyclic phosphodiesterase (CPDase), and a sealing reaction catalyzed by
an RNA ligase. The enzymes that catalyze tRNA healing in yeast and higher eukaryotes are homologous to the
members of the 2H phosphoesterase superfamily, in particular to the vertebrate myelin enzyme 2′,3′-cyclic
nucleotide 3′-phosphodiesterase (CNPase).
Results: We employed different biophysical and biochemical methods to elucidate the overall structural and
functional features of the tRNA healing enzymes yeast Trl1 PNK/CPDase and lancelet PNK/CPDase and compared
them with vertebrate CNPase. The yeast and the lancelet enzymes have cyclic phosphodiesterase and polynucleotide
kinase activity, while vertebrate CNPase lacks PNK activity. In addition, we also show that the healing enzymes are
structurally similar to the vertebrate CNPase by applying synchrotron radiation circular dichroism spectroscopy and
small-angle X-ray scattering.
Conclusions: We provide a structural analysis of the tRNA healing enzyme PNK and CPDase domains together. Our
results support evolution of vertebrate CNPase from tRNA healing enzymes with a loss of function at its N-terminal
PNK-like domain.
Keywords: Cyclic phosphodiesterase, Polynucleotide kinase, Substrate specificity, Protein structure, 2H family, Evolution,
tRNA splicing
Background
Eukaryotic tRNA processing is an essential process, by
which newly synthesized immature pre-tRNA matures
into functional tRNA. The processing of tRNA begins
with endonucleolytic cleavage of the pre-tRNA into an
intron and two tRNA halves that are healed and sealed
by tRNA splicing. The 5′-phosphate ligation pathway,
used by yeast and plants, involves the 5′-phosphate of
the 3′-tRNA half as the junction phosphate of the new
phosphodiester linkage [1, 2]. 5′-phosphate ligation re-
quires three enzymatic activities: a cyclic phospho-
diesterase (CPDase), a polynucleotide kinase (PNK),
and a ligase [1, 3–5]. In contrast to yeast and plants,
animal cells employ two different ligation pathways.
The 3′-phosphate ligation pathway utilizes the 3′-
phosphate of the 5′-tRNA half as the junction phos-
phate; this pathway was first detected in HeLa cell
extracts [6]. The second pathway used by animal cells
is a yeast-type 5′-phosphate ligation pathway, which
has been detected in HeLa cell extracts and in the
lancelet, Branchiostoma floridae [7, 8]. tRNA healing
enzymes appear to be distant homologues of the 2H
phosphoesterase superfamily, which is defined by the
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presence of two conserved H-x-T/S-x (x is a hydropho-
bic residue) motifs [8–10].
The central kinase module of yeast (Saccharomyces
cerevisiae) Trl1 and the N-terminal PNK domain of
lancelet PNK/CPDase show resemblance to the bacterio-
phage T4 PNK and belong to the P-loop phosphotrans-
ferase superfamily. They contain the signature Walker A
motif (P-loop), which is an NTP-binding site in most
NTP-dependent phosphotransferases [8, 11–15]. Initial
functional analysis of the kinase module of yeast Trl1,
using single alanine mutations in the P-loop, revealed
that the P-loop motif (401GCGKT405) is a determinant of
NTP binding [16]. GTP is the preferred in vivo physio-
logical substrate, and yeast Trl1 contains a single NTP
binding site [16]. GTP dependence of the yeast Trl1 kin-
ase domain has also been verified in vitro [17].
The CPDase domain of both yeast Trl1 and lancelet
PNK/CPDase bears resemblance to phosphoesterases of
the 2H superfamily [8–10]. Although 5′-P RNA ligases
of fungi, plants, and animals share essential mechanistic
features and key residues required for their PNK and
CPDase activities, their overall sequence similarity is
low. The presence of the P-loop or Walker A motif (G-
x-G-K-T/S, x is any residue) in the N-terminal domain
and the two H-x-T/S-x motifs in the C-terminal do-
main of vertebrate 2′,3′-cyclic nucleotide 3′-phospho-
diesterase (CNPase) indicates that the PNK/CPDase
domains of yeast Trl1 (Sc PNK/CPDase) and the lance-
let (Bf ) PNK/CPDase are homologues of vertebrate
CNPase [8, 18].
In most vertebrates, CNPase is abundantly expressed
in the myelin sheath, a multilayered proteolipid mem-
brane system. CNPase constitutes 4% of total myelin
protein in the central nervous system (CNS) and 0.4% in
the peripheral nervous system (PNS) [19]. CNPase-
deficient mice develop progressive motor deficits and
die prematurely due to diffuse brain axonal swelling and
neurodegeneration [20]. However, it is not known
whether the late onset of neurodegeneration is caused
by the absence of the CNPase protein as a structural
component of the myelin sheath or the absence of
CNPase enzymatic activity. CNPase has been implicated
in neurodegenerative disorders, such as multiple scler-
osis and schizophrenia [21, 22]. A recent study showed
that CNPase inhibits the assembly of infectious particles
of several primate lentiviruses, including the human im-
munodeficiency viruses HIV-1 and HIV-2, by binding to
the structural protein Gag [23].
The enzymatic activity of CNPase, the hydrolysis of
2′,3′-cyclic nucleotides to 2′-nucleotides, was detected
in brain tissue in the 1960s [24]. Atomic structures of
the C-terminal catalytic domain of human, rat, and
mouse CNPase have illuminated the catalytic role of the
H-x-(T/S)-x motifs and other functionally important
groups in the active site [18, 25–29]. The structure and
function of the N-terminal domain of CNPase remain
poorly characterized. The expression and purification
of the N-terminal domain is difficult compared to the
C-terminal domain, limiting the availability and
characterization of the molecule [30]. Although the N-
terminal domain of CNPase contains the NTP-binding
P-loop motif, and a study by Stingo et al. claims that
nucleotide binding occurs in the N-terminal domain, it
has not been experimentally proven, whether the inter-
action and hydrolysis take place exclusively in the N-
terminal domain, as only full-length CNPase was used
in the experiments [31]. The N-terminal domain of
CNPase binds RNA, mediates dimerization, and inter-
acts with calmodulin (CaM) in a calcium-dependent
manner [27, 32]. CNPase has recently been found to
bind microfilaments and act as an antagonist for myelin
basic protein in myelin membrane compaction [33],
suggesting a structural role – possibly independent of
enzymatic CNPase activity.
Although the structure of the C-terminal phospho-
diesterase domain of vertebrate CNPase has been deter-
mined, no high-resolution structures of either full-length
CNPase or its N-terminal domain are available. The
functional properties of vertebrate CNPase, such as
interactions with membranes, cytoskeletal proteins, and
RNA have been studied; however, the link between its
function in the myelin sheath and its role in RNA
binding is not clear. Hence, structural and functional
characterization of PNK/CPDase would benefit, not
only the field of tRNA splicing, but also studies on
other members of the 2H phosphoesterase family. Since
BfPNK/CPDase could be involved in a new class of 5′-
P RNA ligation, characterization of this enzyme might
improve our understanding of the growing complexity
of animal tRNA splicing. Despite genetic and biochem-
ical analysis of PNK and CPDase domains of yeast Trl1,
no structural information is available for any domain of
the enzyme. Therefore, detailed biophysical and bio-
chemical analysis of ScTrl1 PNK/CPDase and BfPNK/
CPDase is warranted. We generated multiple expres-
sion constructs encoding different segments of the
PNK/CPDase domains of yeast Trl1, as well as full-
length lancelet PNK/CPDase. An array of biophysical
and biochemical methods was employed to characterize
the proteins, including assays for activity, thermal sta-
bility, and folding of the PNK/CPDase domains.
Methods
Sequence and ligation independent cloning
The Protein Crystallographic Construct Design (Pro-
teinCCD) metaserver was used to choose fragments
from different domains of yeast and lancelet healing en-
zymes based on information acquired from various
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prediction servers for secondary structure, disorder,
coiled coils, transmembrane segments, conserved do-
mains, and domain linkers [34]. Multiple expression
constructs encoding the PNK and CPDase domains of
yeast tRNA ligase and full-length lancelet PNK/CPDase
were assembled by sequence and ligation independent
cloning (SLIC). The primers used are listed in (Add-
itional file 1). Briefly, the DNA fragments of interest
were amplified by polymerase chain reaction (PCR) from
pET28a and pET20b plasmids harbouring ScTrl1 and
BfPNK/CPDase, respectively [8]. The amplified products
and linearized pET-his3C-LIC-amp vector (a kind gift
from the Netherlands Cancer Institute) were separately
treated with T4 DNA polymerase. The insert and vector
were annealed, and the resulting plasmid was used to
transform E. coli NEB5α cells (New England Biolabs,
Germany). Transformed colonies were screened by col-
ony PCR for recombinant plasmids that were purified,
verified by sequencing, and used for protein expression.
Protein expression and purification
Large-scale expression of ScTrl1 PNK/CPDase, ScTrl1
CPDase, and BfPNK/CPDase was performed in E. coli
Rosetta(DE3) cells (Novagen, Germany) cultured in LB
medium containing 100 μg/ml ampicillin and 34 μg/ml
chloramphenicol. After reaching an OD600 of 0.5–0.6,
expression was induced with 0.15 mM isopropyl β-D-1
thiogalactopyranoside (IPTG) for 16 h at +18 °C. The
cells were harvested by centrifugation and resuspended
in lysis buffer (50 mM HEPES, pH 7.5, 200 mM NaCl,
10 mM β-mercaptoethanol (β-ME), 20 μg/ml DNase,
Ambion RNase cocktail containing RNase A and RNase
T1(Life Technologies, Germany), 5 mM MgCl2, and
cOmplete mini EDTA-free protease inhibitors (Roche,
Germany)). The suspension was incubated for 20 min at
+4 °C on a tube rotator. The cells were disrupted by
sonication, and debris was removed by centrifugation at
35,000 g for 30 min at +4 °C. The supernatant was ap-
plied to a gravity-flow Ni-NTA column, pre-equilibrated
with lysis buffer. The columns were rotated horizontally
for 1 h to ensure binding of the protein to the matrix.
The column was washed with lysis buffer containing
50 mM imidazole, and bound protein was eluted with
lysis buffer including 500 mM imidazole. The eluted
fractions were studied by SDS-PAGE, and the fractions
containing the protein of expected size were pooled and
dialyzed against the lysis buffer (without imidazole). The
N-terminal hexahistidine tag was cleaved using recom-
binant 3C protease at +4 °C overnight. The cleaved
protein was further purified by Ni-NTA affinity chroma-
tography and dialyzed against the lysis buffer without
imidazole. The dialyzed proteins were concentrated and
applied either to a HiLoad 16/60 Superdex 200 prepara-
tive grade column (column volume: 120 ml; injection
volume: 1 ml) or to a Superdex 75 10/300 GL analytical
grade column (column volume: 24 ml; injection volume:
100 μl), pre-equilibrated with 50 mM HEPES (pH 7.5),
200 mM NaCl, 10 mM β-ME. Equilibration, injection,
and elution were all carried out at a flow rate of 1 ml/
min. The protein-containing peaks were analyzed by
SDS-PAGE, and the fractions containing the proteins of
interest were pooled, concentrated, flash-frozen, and
stored at −80 °C. The identity of the purified proteins
was verified by tryptic peptide mapping using mass spec-
trometry at the Biocenter Oulu Proteomics Core Facility.
Full-length mouse CNPase (MmCNPase, residues 20–
420 of isoform 2), the N-terminal PNK domain
(MmCNP_N, residues 20–180), and the C-terminal cata-
lytic CPDase domain (MmCNP_C, residues 179–398)
were purified using Ni-NTA chromatography, followed
by His-tag cleavage using TEV protease, a second Ni-
NTA step, and size exclusion chromatography (SEC), es-
sentially as described before [30].
Synchrotron radiation circular dichroism spectroscopy
The folding of ScTrl1 PNK/CPDase, BfPNK/CPDase,
and ScTrl1 CPDase was studied by SRCD spectroscopy
on the UV-CD12 beamline at the ANKA Synchrotron.
The proteins purified by SEC were dialyzed into a buf-
fer compatible with SRCD analysis (50 mM potassium
phosphate, pH 6.5). The range of protein concentra-
tions used was between 3.5 and 5 mg/ml. Three spectra
were collected at a scan rate of 14 nm/min, in a de-
mountable 13-μm CaF2 cuvette at a wavelength range
between 260 and 170 nm at 1 nm intervals. A spectrum
from the corresponding buffer was measured for all the
samples and used for background correction. The data
were processed with CDtool [35] and analyzed using
Dichroweb [36].
PNK activity assay
The PNK activity of the N-terminal PNK domain of
ScTrl1 PNK/CPDase and BfPNK/CPDase was assayed
using the synthetic oligonucleotides ribo A20 (A20) and
deoxy A20 (dA20), and a mixture of the two (A20 +
dA20). T4 PNK and ScTrl1 CPDase were used as posi-
tive and negative controls, respectively. The reaction
mixture contained 70 mM Tris, pH 7.5, 10 mM MgCl2,
and 5 mM DTT, 2 μg of enzyme, and 100 pmol A20 or
dA20 or both. 55 pmol of radioactively labelled [γ
32P]
ATP were added to each reaction mixture, and the vol-
ume of the mixtures was adjusted to 40 μl with
diethylpyrocarbonate-treated water. The samples were
incubated at +37 °C, and 8-μl aliquots were removed at
different time points (1, 15, 30, and 60 min). Each sam-
ple was quenched with 8 μl of 2X urea sample loading
buffer (Invitrogen Novex) and heated at +90 °C for
4 min. The samples were analyzed by electrophoresis
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using a 15% Mini-PROTEAN TBE-Urea gel (Bio-Rad),
at 150 V for 85 min, and visualized using PhosphorIma-
ger analysis.
CPDase activity assay
Kinetic measurements were carried out as previously de-
scribed [30, 37]. In this assay, CPDase hydrolyzes the
phosphodiester bond in β-nicotinamide adenine di-
nucleotide 2′,3′-cyclic monophosphate (2′,3′-cNADP+),
and the resulting nicotinamide adenine dinucleotide
phosphate (NADP+) is reduced to NADPH by glucose-
6-phosphate dehydrogenase and used to transform
glucose-6-phosphate to 6-phosphoglucanolactone. The
quantity of NADPH formed during the coupled enzym-
atic reaction is a direct measure of CPDase activity [38].
The assay mixture contained 100 mM MES, pH 6.0,
3 mM MgCl2, 5 mM glucose-6-phosphate, and 0.6 U
glucose-6-phosphate dehydrogenase. 500 ng of the puri-
fied enzyme was mixed with varying concentrations of
the substrate, 2′,3′-cNADP+ (0, 0.05, 0.1, 0.2, 0.5, and
1.0 mM), and NADPH production was measured spec-
trophotometrically at 340 nm, using the absorption coef-
ficient 6.22 cm−1mM−1. The measurements were carried
out in triplicate at +25 °C using 96-well flat-bottom
transparent plates with the TECAN Infinite M200 fluor-
escence spectrophotometer and iControl software.
Thermal stability assay
Fluorescence-based thermal shift assays were carried out
in triplicate, essentially as described [39]. Measurements
were performed with a CFX96 RealTime PCR system
(BioRad), using a 96-well thin-wall PCR plate. 1–5 μg of
protein and 1–2 X SYPRO Orange dye were included in
a total volume of 25 μl per condition. The plate was
sealed with optical-quality adhesive film (BioRad) and
heated from +25 °C to +99 °C in 0.5 °C increments. A
total of 80 different conditions, varying in pH, salt type
and concentration, and the presence of ligands, were
screened. The fluorescence of SYPRO Orange was mea-
sured using excitation at 490 nm and emission at
575 nm. The apparent thermal melting points (Tm) were
determined for each construct under all 80 conditions.
Small-angle X-ray scattering
SAXS measurements were carried out on the EMBL
beamline X33 at DESY, Hamburg (Germany), the I911-4
SAXS beamline of MAX-Lab in Lund (Sweden), and the
P12 BioSAXS beamline at PETRA-III, DESY, Hamburg.
The ScTrl1 PNK/CPDase and BfPNK/CPDase eluted
from SEC both as a dimer and as a monomer. These
fractions were collected separately, concentrated, and
used for SAXS measurements; only the data from the
monomeric fraction were analyzed in detail, as
dimerization was likely an artifact of non-specific
disulphide formation. Sample concentrations were 1–
10 mg/ml. Monomeric BSA was measured first as a MW
standard. Solvent scattering from the corresponding buf-
fer was measured identically before and after each
sample, and the average background scattering was sub-
tracted. The data were analyzed with the ATSAS [40]
suite, as described [41, 42]. The data were processed
using PRIMUS [43]. Distance distributions were calcu-
lated using GNOM [44], and ab initio bead modeling
was done with DAMMIF [45]. DAMAVER [46] was used
for model averaging. GASBOR [47] was used for building
chain-like ab initio models, and MONSA [48] was used to
assemble a 2-phase model of ScTrl1 PNK/CPDase,
employing data from both ScTrl1 PNK/CPDase and
ScTrl1 CPDase. The models were compared in PyMOL.
Results and discussion
Protein expression and purification
A total of nine expression clones including eight for
different segments of yeast Trl1 and one for lancelet
PNK/CPDase were prepared (Fig. 1). All constructs
contain an N-terminal hexahistidine tag followed by a 3C
protease cleavage site and the corresponding PNK/
CPDase domain. The expression level of the different con-
structs was screened in three E. coli cell lines [BL21(DE3),
BL21(DE3) CodonPlus RIPL, and Rosetta(DE3)] under
different expression conditions, including various inducer
concentrations and post-induction growth temperatures.
The constructs encoding different regions of the Sc PNK
domain did not show any expression in the three cell lines
tested; the remaining five constructs could be expressed.
The same pattern was observed previously for the yeast
ScTrl1 PNK domain and the N-terminal domain of mouse
CNPase [16, 30]. The solubility of the proteins expressed
in Rosetta (DE3) was remarkably high. Screening growth
conditions post-induction revealed longer incubation at
lower temperatures to be the optimal expression strategy.
For large-scale production of ScTrl1 PNK/CPDase and
BfPNK/CPDase, up to 8 l of culture were used to obtain
~5 mg of protein, whereas 2 l of culture was sufficient to
achieve similar quantities of the ScCPDase domains.
The expressed proteins were initially purified by Ni-
NTA affinity chromatography and SEC (Additional file
2 & Figs. 2 and 3). ScTrl1 PNK/CPDase and BfPNK/
CPDase eluted as double peaks with elution volumes
corresponding to dimeric and monomeric forms. The
fractions from each of the two peaks were collected
separately, concentrated, and analyzed by SDS PAGE.
Both peaks contained pure protein. The vertebrate
homologue, mouse CNPase, exhibits similar oligomeric
behaviour, and in this case, the N-terminal RNA-
binding domain mediated dimerization [27]. The
addition of either 10 mM β-ME or 5 mM DTT in the
lysis and purification buffers inhibited dimerization of
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Fig. 1 Preparation of expression constructs. Scheme of the constructs prepared for the kinase and phosphodiesterase domains of yeast Trl1 and
for lancelet PNK/CPDase. 6H indicates the hexa-histidine tag, and 3C indicates the 3C protease cleavage site
Fig. 2 Purification of BfPNK/CPDase. a SDS PAGE from a Ni-NTA purification of BfPNK/CPDase. SF: supernatant flow-through, W: wash, E1-E7: fractions
eluted with 500 mM imidazole, M: marker. The calculated size of the protein was 60.3 kDa. b Superdex75 SEC profile of BfPNK/CPDase. The blue curve
shows a mixture of monomer and dimer in the absence of any reducing agent, and the green curve shows the monomer in the presence of 5 mM β-
ME. The single monomeric peak (green) indicates that the dimer formation is inhibited by β-ME. c SDS-PAGE from a SEC purification of BfPNK/CPDase
in the absence of a reducing agent. M: marker, Di: BfPNK/CPDase dimer, Mo: BfPNK/CPDase monomer
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ScTrl1 PNK/CPDase and BfPNK/CPDase, indicating
that the dimers are linked by a disulphide. Most likely
the physiologically relevant form of each protein is
monomeric.
The elution profiles of the CPDase constructs contained
a single symmetric peak (Fig. 3b, c), and no oligomerization
or RNA binding was detected. The absence of dimerization
and RNA binding in the CPDase domain suggest that
these processes require the N-terminal PNK domain.
Similarly, the N-terminal PNK-like domain of mouse
CNPase is involved not only in dimerization, but also
in RNA binding [27]. The purified proteins were easily
degraded upon storage at +4 °C. Hence, immediate
flash-freezing and storage of the purified proteins in
the freezer was essential. Since the stability of ScTrl1
CPDase was found to be comparatively better than the
other two CPDase protein variants, it was used in fur-
ther biophysical and biochemical experiments.
PNK/CPDase enzymes interact with Eschericia coli nucleic
acids
During the purification of ScTrl1 PNK/CPDase and
BfPNK/CPDase, a large peak was always present right
after the void volume of the SEC column (Fig. 4a). Since
the absorbance at 260 nm was very high for this peak,
co-purification of a nucleic acid, possibly RNA, from the
expression host, was suspected. To identify the nucleic
acid bound to the protein, the fractions eluted around
Fig. 3 Yeast PNK/CPDase and CPDase purified by size exclusion chromatography. a Superdex200 SEC profile of ScTrl1 PNK/CPDase monomer
(dark red) and ScTrl1 CPDase (blue). b Superdex75 SEC profile of ScTrl1 CPDase (blue) and ScTrl1 (N-) CPDase (green). c Superdex75 SEC profile of
ScTrl1 CPDase (blue) and ScTrl1 (N+) CPDase (orange). The CPDase proteins elute around the same elution volume and exist as monomers
Fig. 4 PNK/CPDase interacts with E. coli RNA. a Superdex 200 SEC profile of ScTrl1 PNK/CPDase (continuous lines) and BfPNK/CPDase (dashed lines).
The peaks close to the void volume with A260 (green) higher than A280 (blue) indicate the presence of a nucleic acid. VO: column void volume.
b Agarose gels of BfPNK/CPDase and ScTrl1 PNK/CPDase. L: DNA ladder, 1: The protein-nucleic acid complex eluted near the void volume from SEC, 2:
DNase-treated protein-nucleic acid complex, 3: RNase-treated protein-nucleic acid complex. RNase degrades the nucleic acid, confirming that the co-
purified molecule is, in fact, RNA
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the void volume in SEC were treated with DNase and
RNase A. Agarose gels of nuclease-treated samples
show that the bright smear in the larger elution fraction
and in the same fraction treated with DNase was not
found in the presence of RNase A (Fig. 4b). This find-
ing confirms that the co-purified nucleic acid impurity
contained RNA. In addition, DNA was present in the
BfPNK/CPDase sample. When a combination of RNase
A and RNase T1 was added in the lysis buffer during
subsequent purification, the A260 peak height remark-
ably decreased, additionally proving that the contamin-
ant was RNA.
The behaviour of PNK/CPDase proteins in these as-
says was highly similar to the uracil-DNA degrading
factor and mouse CNPase [27, 49]. CNPase has also
been shown to interact with RNA in vitro and co-purify
with poly(A)+ RNA; the catalytic domain of CNPase
has been shown to be sufficient for binding with single
stranded RNA homopolymers [50, 51]. However, a pull-
down assay with mouse CNPase and poly(A)-sepharose
indicated that the N-terminal domain binds RNA more
efficiently than the C-terminal domain [27]. The ab-
sence of the peak closely following the void volume
during SEC purification of the yeast CPDase domain in-
dicates the N-terminal PNK domain is required for
RNA binding, at least in the case of E. coli RNA.
Bacterially expressed PNK/CPDase and CPDase proteins
are folded
The folding state of the purified proteins was analyzed
by SRCD spectroscopy. Visual inspection of the SRCD
spectra indicates that the PNK/CPDase and CPDase pro-
teins were folded, containing a mixture of α helix and β
strand. SRCD spectra from ScTrl1 PNK/CPDase and
BfPNK/CPDase show a similar shape (Fig. 5a), indicating
the presence of similar amounts of regular secondary
structure. The spectra also indicate that the N-terminal
truncation of ScTrl1 CPDase is less folded than ScTrl1
CPDase (Fig. 5b). The latter is indicative of sub-optimal
folding of the truncated construct.
Ligand binding improves thermal stability
Since the stability of the monomers of both ScTrl1 PNK/
CPDase and BfPNK/CPDase during and after purification
was initially low, the identification of a stabilizing buffer
condition was necessary. A thermal stability assay was
used to identify suitable buffer conditions that would offer
increased stability of the protein. The melting curves and
corresponding Tm values of ScTrl1 PNK/CPDase, ScTrl1
CPDase, and BfPNK/CPDase indicate that all three pro-
teins are most stable around pH 7.5. The combination of
50 mM HEPES, pH 7.5, and 150 mM NaCl was identified
as an optimal stabilizing buffer.
To analyze the effect of ligands on the thermal stability
of the proteins, two known substrates of CPDase, 2′,3′-
cCMP and 2′,3′-cNADP+, and the product NADP+ were
included in the screen. The Tm values indicate that 2′,3′-
cNADP+ improves the thermal stability of all three pro-
teins tested (Fig. 6, Table 1); however, 2′,3′-cCMP and
NADP+ do not influence the stability of any of them. The
highest melting points obtained for ScTrl1 PNK/CPDase
and BfPNK/CPDase were +63 °C and +48 °C, respectively,
both in the presence of 2′,3′-cNADP+. ScTrl1 CPDase
was found to be the most stable among the proteins
tested, with a melting temperature of +72 °C in a buffer
containing 50 mM HEPES, pH 7.5, 150 mM NaCl, and
1 mM 2′,3′-cNADP+. Mouse CNPase is more stable at
pH 5.5 with higher salt than at neutral pH with lower salt,
which stabilizes the yeast and lancelet proteins [30]. The
thermal stability of ScTrl1 CPDase is also higher than that
of the mouse CNPase catalytic domain and its mutated
variants [28, 29].
PNK/CPDase enzymes possess polynucleotide kinase
activity
The assay to test the PNK activity of the purified ScTrl1
PNK/CPDase and BfPNK/CPDase involves transfer of
Fig. 5 SRCD spectra of purified proteins. a ScTrl1 PNK/CPDase (red) and BfPNK/CPDase (green). b ScTrl1 CPDase (blue) and ScTrl1 (N-) CPDase
(purple). The SRCD spectra indicate that all tested proteins are folded
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the 32P-labelled terminal phosphate from [γ32P] ATP to
a 20-mer 5′-OH synthetic RNA (A20) or DNA oligo-
nucleotide (dA20). To study the substrate preferences of
the enzymes on RNA and DNA oligonucleotide sub-
strates, the transfer of the radiolabelled phosphate to a
mixture of A20 and dA20 was also analyzed. The time-
dependent transfer of the phosphate from [γ32P] ATP
to the 5′-OH groups of the synthetic oligonucleotides
indicates that both ScTrl1 PNK/CPDase and BfPNK/
CPDase possess PNK activity (Fig. 7a-b). ScTrl1
CPDase did not catalyze phosphoryl transfer (Fig. 7c).
The results indicate that ScTrl1 PNK/CPDase prefers
A20 (Fig. 7a) and BfPNK/CPDase strongly prefers dA20
(Fig. 7b).
BfPNK/CPDase was previously shown to prefer
DNA over RNA, whereas another lancelet PNK, Bf
Clp1, was reported to act exclusively on RNA [8].
This finding suggested a possible role for BfPNK/
CPDase in DNA repair. The fact that we saw DNA
co-purifying with BfPNK/CPDase and that the enzyme
preferred the DNA substrate in the PNK assay sup-
port this hypothesis. The decrease in size of the la-
belled dA20 oligonucleotide during the assay could be
related to an unknown activity of BfPNK/CPDase to-
wards DNA. The homologue of yeast and lancelet
PNK/CPDase, mammalian CNPase, was found to res-
cue a yeast strain with an inactivating mutation in
the CPDase domain of yeast tRNA ligase, but not a
strain with a mutated kinase domain [52]. Thus, it
appears that the N-terminal PNK-like domain of ver-
tebrate CNPase is not functionally a PNK. This is
supported by our results from the PNK activity as-
says. MmCNPase, as well as its two domains separ-
ately, were inactive, while the homologous yeast and
lancelet PNK/CPDase proteins were active (Fig. 7a, b,
Additional file 3). This finding also supports the hy-
pothesis that vertebrates might employ the 5′-P RNA
ligation pathway only as an alternate to 3′-P RNA
Fig. 6 Thermal stability assay. a A selection of thermal shift assay melting curves for ScTrl1 PNK/CPDase. Colour code: Violet - 50 mM citric acid,
pH 5.5, 150 mM NaCl; Dark red - 50 mM MOPS, pH 6.5, 500 mM NaCl; Orange - 50 mM imidazole, pH 8.0, 150 mM NaCl; Light blue - 50 mM
HEPES, pH 7.5, 150 mM NaCl; Green - 50 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM 2′,3′-cNADP+. b A selection of thermal shift assay melting curves
for Bf PNK/CPDase. Colour code: Dark red - 50 mM MOPS, pH 6.5, 500 mM NaCl; Blue - 50 mM MES, pH 7.0, 150 mM NaCl; Light blue - 50 mM
HEPES, pH 7.5150 mM NaCl; Green - 50 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM 2′,3′-cNADP+. A clear increase in the melting temperature can be
observed, induced by buffer conditions with pH 7.5, low salt concentration, and 2′,3′-cNADP+
Table 1 Comparison of Tm values for ScTrl1 PNK/CPDase, ScTrl1 CPDase, and BfPNK/CPDase. The highest Tm values are indicated in
bold
Protein Buffer condition Tm (°C)
ScTrl1 PNK/CPDase 50 mM HEPES, pH 7.5, 150 mM NaCl 55
50 mM imidazole, pH 8.0, 150 mM NaCl 50
50 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM 2′,3′-cNADP+ 63
ScTrl1 CPDase 50 mM HEPES, pH 7.5, 150 mM NaCl 58
50 mM imidazole, pH 8.0, 150 mM NaCl 55
50 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM 2′,3′-cNADP+ 72
BfPNK/CPDase 50 mM HEPES, pH 7.5, 150 mM NaCl 43
50 mM MES, pH 7.0, 500 150 mM NaCl 43
50 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM 2′,3′-cNADP+ 48
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ligation and, thus, require only the exclusive poly-
nucleotide kinase (Clp1) for the healing reaction, and
not the N-terminal PNK-like domain of CNPase.
PNK/CPDase and CPDase enzymes possess cyclic
nucleotide phosphodiesterase activity
The CPDase activity of ScTrl1 PNK/CPDase, BfPNK/
CPDase, and ScTrl1 CPDase was assayed using 2′,3′-
cNADP+ as substrate in a coupled enzyme assay [37, 38].
The results indicate that all tested constructs are active in
the phosphodiesterase reaction (Table 2) and that the
activity is comparable to that of the different constructs of
mouse and rat CNPase. Thus, CPDase activity is a com-
mon denominator for 2H enzymes across kingdoms of
life.
PNK/CPDase enzymes are elongated in solution
SAXS measurements were carried out to determine low-
resolution structural models of the proteins and to
analyze their oligomeric state in solution. Although
SAXS data were collected for all the five expressed con-
structs, only three of them, the ScTrl1 PNK/CPDase, the
Fig. 7 Polynucleotide kinase activity assay. PNK reaction mixtures of a ScTrl1 PNK/CPDase, b BfPNK/CPDase, and c ScTrl1 CPDase. The reactions
were carried out in the presence of Mg2+, with ATP as phosphate donor and with either A20, dA20, or both as acceptors. Both ScPNK/CPDase and
BfPNK/CPDase display PNK activity with a clear substrate preference. The ScCPDase domain alone is expectedly inactive. The arrow represents the
direction of electrophoresis
Table 2 Kinetic parameters for the CPDase activity of different constructs on 2′,3′-cNADP+
Protein Km (μM) kcat (s−1) kcat/Km (μM−1 s−1)
Enzymes used in the study
BfPNK/CPDase (500 ng) 440 ± 50 510 ± 20 1.15
ScTrl1 PNK/CPDase (500 ng) 420 ± 35 317 ± 15 0.75
ScTrl1 CPDase (500 ng) 237 ± 27 275 ± 18 1.16
Homologous enzymes
MmCNPase - full length (500 ng) [30] 193 ± 26 270 ± 10 1.40
MmCNPase - catalytic domain (500 ng) [30] 445 ± 41 570 ± 19 1.28
Rat CNPase - full length [37] 263 ± 12 836 ± 11 3.2
Rat CNPase - catalytic fragment [37] 295 ± 22 1690 ± 39 5.7
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ScTrl1 CPDase, and the BfPNK/CPDase, yielded good-
quality SAXS data, and only these were used for further
processing and modeling. The best datasets were col-
lected between 3 and 4 mg/ml, with a strong scattering
signal and without significant interparticle effects, as
shown by the linearity of the Guinier plot (Fig. 8a, b).
The monomeric ScTrl1 PNK/CPDase and BfPNK/
CPDase display similarly elongated conformations, with
BfPNK/CPDase being more extended (Fig. 8a, e, f and
Table 3). The estimated Porod volume is in agreement
with a monomeric form of both proteins. The p(r) profile
displays a single peak with shoulders for both yeast and
lancelet PNK/CPDase proteins (Fig. 8c), indicating an
asymmetric scattering particle, possibly containing two
domains bridged by a flexible linker. Dimensionless Kratky
plots (Fig. 8d) further show that BfPNK/CPDase is the
most flexible of the studied samples, in line with its rela-
tively large volume-to-mass ratio (Table 3).
The 3D models for both PNK/CPDases are consist-
ent with an arrangement, where the two domains
form an elongated assembly. The model suggests that
the active sites of the PNK domain and CPDase do-
main are accessible and not being blocked by the
neighbouring domain. An open active site facilitates
substrate binding without the need for large conform-
ational changes. If the domains would cover each
other more extensively, the shape of the molecule
would be more globular.
The solution structure of full-length mouse CNPase is
similar to that of the monomeric ScTrl1 PNK/CPDase and
BfPNK/CPDase [28], although somewhat more compact,
reflecting the presence of large flexible insertions in the
yeast and lancelet enzymes. Mouse CNPase is a monomer
with an elongated conformation in solution [28]. Although
the molecular masses of monomeric ScTrl1 PNK/CPDase
[50.52 kDa] and monomeric mouse CNPase [44.8 kDa]
are close to each other, the Dmax and Rg values are com-
paratively higher for the ScTrl1 PNK/CPDase (Table 3).
This could be due to the presence of a flexible linker re-
gion between the N-terminal PNK and C-terminal
CPDase domains in ScTrl1 PNK/CPDase: this segment is
absent in mouse CNPase (Fig. 9a). Based on SAXS data
and molecular modelling, the C-terminal membrane-
anchoring tail of the mouse CNPase lies in the middle re-
gion of the molecule, enabling the association of the active
site to the vicinity of the lipid bilayer [28].
CPDase is compact in solution
The molecular size determined from the SAXS profile of
ScTrl1 CPDase indicates that the molecule is more com-
pact in solution than ScTrl1 PNK/CPDase and exists as
a monomer (Fig. 8a, c, d, f & g, Table 3). Molecular mass
Fig. 8 SAXS analysis of Bf and ScTrl1 PNK/CPDases. a Scattering curves from monomeric Bf (blue) and ScTrl1 (red) PNK/CPDases and the ScTrl1
CPDase domain (green). The curves have been displaced for clarity. b Guinier plots for the samples in (A), plotted between 0.8 < sRg < 1.3. The
curves have been moved in the y dimension for clarity. c Distance distribution functions for the samples shown in (A). d Dimensionless Kratky
plots. The cross marks the expected peak position for a folded globular protein (x = 1.732, y = 1.1). BfPNK/CPDase is most flexible of the proteins.
e-g Ab initio 3D models for BfPNK/CPDase, ScTrl1 PNK/CPDase, and the ScTrl1 CPDase domain, respectively. The DAMMIF bead model is shown
by spheres and the GASBOR chain-like model as a surface in each panel. h Comparison of the 2-phase MONSA model of ScTrl1 PNK/CPDase (left)
with the earlier published SAXS structure of full-length MmCNPase (right) [28]. The positions of the N-terminal PNK domain and the C-terminal
CPDase domain are indicated for both proteins. See Table 3 for the chi2 values corresponding to the fit between the raw data and the models
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determination shows the presence of a monomer. The
Porod volume is also in line with the presence of mono-
meric ScTrl1 CPDase. The SAXS model shows the pres-
ence of an extension presumably in the N terminus of
the protein; this tail possibly arises from the interdomain
linker at the N terminus of the construct, suggesting the
requirement for a shorter construct of the protein with-
out the N terminal insertion to facilitate crystallization.
The solution structure of ScTrl1 CPDase resembles
that of the catalytic domain of mouse CNPase [27]. The
mouse CNPase catalytic domain is also monomeric in
solution. Both ScTrl1 CPDase and the catalytic domain
of mouse CNPase adopt an elongated conformation pos-
sibly due to the opening of the active-site cleft, as found
in the NMR structure of rat CNPase catalytic domain
[25, 27]. The mouse CNPase catalytic domain displays a
more compact structure in the presence of citrate and
the ligand also reduces aggregation of the protein [27]. It
has been suggested that the overall solution conform-
ation of fully active CNPase might be more open than
that seen in the crystal structures, in which the enzyme is
bound to citrate and sulphate [27]. Different lengths of the
mouse CNPase catalytic domain have been studied by
SAXS [27]. The presence of a C-terminal tail does not
alter the conformation of the catalytic domain in solution,
whereas N-terminally extended CNPase catalytic domain
has a higher radius of gyration. Both N- and C-terminally
extended protein is remarkably more elongated [27]. The
symmetric peak of the p(r) for ScTrl1 CPDase shows that
the protein, similarly to the mouse CNPase catalytic
domain, is more compact than the protein variants that
also contain the N-terminal domain (Fig. 8c).
The solution shapes and behaviour of the PNK/
CPDases and the CPDase are in many aspects compar-
able to those of the full-length mouse CNPase and its
catalytic domain, respectively. The differences are likely
caused by the relatively large insertions compared to
CNPase: the yeast enzyme has a long insertion between
the PNK and CPDase domains, while the lancelet en-
zyme has insertions in two loop regions of the CPDase
domain (Fig. 9a, b). The SAXS model of full-length
mouse CNPase indicates that the N-terminal PNK-like
and the C-terminal phosphodiesterase domains form an
elongated assembly [28], and as shown here, the same is
true for the yeast and lancelet enzymes. The biphasic
model built for the yeast enzyme (Fig. 8h) compares well
to the mouse CNPase solution structure. Thus, the do-
main arrangements of the yeast and lancelet PNK/
CPDase in solution resemble that of CNPase. An open
elongated conformation of the full-length protein could
be crucial for substrate binding [28]. Superposition of a
homology model of the CPDase domain of BfPNK/
CPDase and the catalytic domain of MmCNPase shows
that the active site consisting of the 2H motifs is struc-
turally conserved [27, 53] (Fig. 9b). The homology model
of the lancelet CPDase domain contains a symmetrical
bilobed tertiary structure, which is similar to the crystal
structures of the catalytic domain of mouse and human
CNPase [26–29]. The inserted loops within the CPDase
domain of BfPNK/CPDase (Fig. 9b) were also the most
flexible in the recently-determined structure of a bacterial
2H phosphoesterase, LigT from E. coli [51].
Comparison of the SAXS models of ScTrl1 PNK/
CPDase, BfPNK/CPDase, and ScTrl1 CPDase with the
SAXS structural parameters of the homologous mouse
CNPase indicates that the structural and hydrodynamic
properties of the different constructs can be explained
by the presence of sequence insertions in the yeast and
lancelet enzymes. A structural model of the PNK/
CPDase proteins (Fig. 9c) can be proposed based on the
Table 3 Structural parameters derived from experimental SAXS data and comparison to known parameters of mouse CNPase
Protein ScTrl1 PNK/CPDase BfPNK/CPDase ScTrl1 CPDase MmCNPase [28] MmCNPase catalytic
domain [27]
Dmax (nm) 11.6 14.3 8.5 8.8 7.1
Guinier Rg (nm) 3.37 4.16 2.48 2.6 2.13
Real-space Rg (nm) 3.79 4.83 2.69 - -
VP (nm
3) 78.6 137.7 50.1 - 44.4
Ab initio V (nm3)/estimated
MW of globular particle (kDa)
106/78.7 212/157.4 30.5/22.6 - -
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determined 3-dimensional shapes. Yeast PNK/CPDase
exhibits an elongated conformation with the presence of
a possibly flexible region between the N-terminal PNK
and C-terminal CPDase domains. Removal of the flexible
region, which is not present in mouse CNPase, might
aid in crystallization of the domains separately. The
model also indicates that the two loop insertions in the
CPDase domain in lancelet PNK/CPDase result in an
even more elongated molecule, and these long loops
point away from the PNK domain at the other end of
the molecule. It is possible that BfPNK/CPDase also has
a flexible region at its N terminus.
Conclusions
The open elongated conformation of the PNK/CPDases
might play a role in RNA substrate binding; however,
this needs to be confirmed by high-resolution structures
of the enzymes with bound substrates. Based on
Fig. 9 Domain arrangement of PNK/CPDase proteins. a Multiple sequence alignment using T-Coffee [54]. Aligned sequences of ScTrl1 PNK/CPDase
(Sc), BfPNK/CPDase (Bf), MmCNPase (mouse), and HsCNPase (human). The N-terminal P-loop motif and two C-terminal H-x-(T/S)-x motifs are underlined
in red and green, respectively. b Superposition of the homology model of the CPDase domain of BfPNK/CPDase (blue), generated using Phyre2, and the
crystal structure of the catalytic domain of MmCNPase (yellow) [PDB ID: 2YDB] [27, 53]. The black arrows point to the locations of flexible loops in the
homology model of the CPDase domain of BfPNK/CPDase (blue). c The overall three-dimensional shapes of PNK/CPDase proteins determined in this
study can be used to propose a structural arrangement of the domains
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currently available structural data, we can conclude that
both enzymes display structural similarities to other
members of the 2H-phosphoesterase family - not only at
the level of conserved sequence motifs, but also in their
respective domain arrangements. The yeast and lancelet
healing enzymes possess both PNK and CPDase activ-
ities, whereas the mouse CNPase, which also binds
RNA, has no PNK activity. This suggests a loss of func-
tion at the CNPase N-terminal PNK-like domain over
the course of evolution. On the other hand, BfPNK/
CPDase may have a unique substrate specificity within
the family with respect to its PNK activity. Thus, our
results on the structure and function of tRNA healing
enzymes from yeast and lancelet provide evidence sup-
porting the evolution of vertebrate CNPase from func-
tional tRNA healing enzymes.
Additional files
Additional file 1: Table S1. Primers used for PCR amplification of target
DNA fragments. (PDF 54 kb)
Additional file 2: Figure S1. The yeast PNK/CPDase and CPDase proteins
purified by Ni-NTA affinity chromatography. A) SDS-PAGE from a Ni-NTA
purification of ScTrl1 PNK/CPDase. M: marker, E1-E8: fractions eluted with
500 mM imidazole. The calculated size of the protein was 52.7 kDa. B) SDS-
PAGE from Ni-NTA purifications of ScTrl1 CPDase and ScTrl1 (N+) CPDase. M:
marker, SF1 and W1 are supernatant and wash flow-through samples from
the purification of ScTrl1 CPDase, E1-E5: ScTrl1 CPDase fractions eluted with
500 mM imidazole. The calculated size of the protein was 32.2 kDa. SF2 and
W2 are supernatant and wash flow-through samples from the purification
of ScTrl1 (N+) CPDase, E6-E10: ScTrl1 (N+) CPDase fractions eluted with
500 mM imidazole. The calculated size of the protein was 32.4 kDa. C) SDS
PAGE from a Ni-NTA purification of ScTrl1 (N-) CPDase. SF: supernatant flow-
through, W: wash flow-through, E1-E10: fractions eluted with 500 mM
imidazole, M: marker. The calculated size of the protein was 29.6 kDa.
(PDF 220 kb)
Additional file 3: Figure S2. Polynucleotide kinase activity assay. PNK
reaction mixtures of A) T4 PNK, B) MmCNPase C) MmCNP_N and D)
MmCNP_C. The reactions were carried out in the presence of Mg2+, with ATP
as phosphate donor and with either A20, dA20, or both. T4 PNK was used as a
positive control to validate the assay setup. The MmCNP domains were
tested separately, with a negative result in the chosen assay conditions. The
arrow represents the direction of electrophoresis. (PDF 387 kb)
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